Know a Market’s Next Move — Before It Happens.
Know a Market’s Next Move — Before It Happens.
On February 8th, we shared with our members a full year forecast for the CBOE Volatility Index (a.k.a “the VIX”). That article can be found here. Having a roadmap of the VIX can help point us to moments in time…
This is a weekly snapshot showing an objective weekly trend model applied to the Nasdaq and QQQ ETF using long-term historical data for those interested in broader market regime context. The purpose of these charts is to provide transparency into…
This is a 2-part video series reviewing what to look for “under the hood” of the stock market during times of volatility or consolidation to better understand what institutional funds are doing with their capital. Part 1 below is a…
The SPDR S&P Oil & Gas Exploration & Production ETF (Ticker: XOP) is a play on the energy sector. The XLE ETF is also an option. The below chart is a weekly chart of XOP. As of today’s open, energy…
Pfizer’s stock (Ticker: PFE) has seen bullish bias since April of 2025. Look for the stock price to consolidate between now and the dates shown on the chart. A Blue Wave with an 84% probability attached and a target ROI…
This is a weekly snapshot showing an objective weekly trend model applied to the Nasdaq and QQQ ETF using long-term historical data for those interested in broader market regime context. The purpose of these charts is to provide transparency into…
The video below is a review of the March 2026 Nasdaq/QQQ forecast and a video explanation of the April 2026 QQQ forecast. April 2026 Nasdaq/QQQ Forecast: Chart expands upon click.
The below chart is a daily chart of the Invesco QQQ ETF (Ticker: QQQ). QQQ is a near 1-for-1 representation of the tech-heavy Nasdaq Composite. Since October 29th 2025, the Nasdaq (and QQQ) have been seeing consolidation (selling pressure) with…
This is a weekly snapshot showing an objective weekly trend model applied to the Nasdaq and QQQ ETF using long-term historical data for those interested in broader market regime context. The purpose of these charts is to provide transparency into…
Abbott Laboratories (Ticker: ABT) has been under heavy selling pressure since March 2025. The selling is likely now overdone and the stock should see bullish bias from here into July 2026. A Blue Wave forecast is in agreement with the…